Pharmaceutical composition containing hydantoin derivative

Details Pharmaceutical composition containing hydantoin derivative Pharmaceutical composition containing hydantoin derivative

A - Human Necessities

61

K

167/237

A61K 31/415 (2006.01)

Patent

CA 2021923

A Pharmaceutical composition which inhibits aldose reductase enzymes is disclosed. In the composition, a hydantoin derivative known per se is uniformly dispersed in a high molecular carrier for the hydantoin derivative. The composition may further contain a water soluble high molecular substance. The composition is administered to prevent or cure complications due to diabetes.

Une composition pharmaceutique qui inhibe les enzymes aldose-réductase est divulguée. Dans la composition, un dérivé de l'hydantoïne connu en soi est dispersé uniformément dans un transporteur de poids moléculaire élevé. La composition peut également contenir une substance hydrosoluble de poids moléculaire élevé. La composition est administrée pour prévenir ou guérir les complications du diabète.

Affiliated with

Also associated with

Rating

Pharmaceutical composition containing hydantoin derivative does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Pharmaceutical composition containing hydantoin derivative, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Pharmaceutical composition containing hydantoin derivative will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-1695710